Cardiovascular biomarkers and sex: the case for women (Q38543356)

4 September 2017

1 reference

title

Cardiovascular biomarkers and sex: the case for women (English)

1 reference

4 September 2017

0 references

Lori B Daniels

1

1 reference

PubMed ID

26149486

4 September 2017

Alan S Maisel

series ordinal

2

1 reference

PubMed ID

26149486

4 September 2017

language of work or name

English

0 references

publication date

7 July 2015

1 reference

Nature Reviews Cardiology

4 September 2017

1 reference

4 September 2017

12

1 reference

4 September 2017

10

1 reference

4 September 2017

588-596

1 reference

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

4 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Risk stratification in women enrolled in the Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Neurohormonal and clinical sex differences in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Sex-specific acute heart failure phenotypes and outcomes from PROTECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Missed diagnoses of acute cardiac ischemia in the emergency department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascul

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Third universal definition of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-T

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Plasma brain natriuretic peptide concentration: impact of age and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Impact of age and sex on plasma natriuretic peptide levels in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Influence of sex and hormone status on circulating natriuretic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Heart failure in women: a need for prospective data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Systolic and diastolic heart failure in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Diagnostic value of a rapid test for B-type natriuretic peptide in patients presenting with acute dyspnoe: effect of age and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: a 30-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Biochemical detection of left-ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the Malmö Diet and Cancer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Galectin-3: an open-ended story

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Galectin-3: a novel mediator of heart failure development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Elevated galectin-3 precedes the development of CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

The fibrosis marker galectin-3 and outcome in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Using ST2 in cardiovascular patients: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Soluble ST2 is not independently associated with androgen and estrogen status in healthy males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Representation of women in randomized clinical trials of cardiovascular disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Neurotensin: peptide for the next millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Cloning of human neurotensin/neuromedin N genomic sequences and expression in the ventral mesencephalon of schizophrenics and age/sex matched controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Neuromedin N: high affinity interaction with brain neurotensin receptors and rapid inactivation by brain synaptic peptidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Production of recombinant large proneurotensin/neuromedin N-derived peptides and characterization of their binding and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Proneurotensin 1-117, a stable neurotensin precursor fragment identified in human circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Analytical validation of a high-sensitivity cardiac troponin T assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Effects of acidosis on phosphorylation of phospholamban and troponin I in rat cardiac muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

A sexually dimorphic pattern of growth hormone secretion in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Gender, age, body mass index, and IGF-I individually and jointly determine distinct GH dynamics: analyses in one hundred healthy adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Galectin-3 in heart failure: high levels are associated with all-cause mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

Effect of neurotensin on exocrine pancreatic secretion in dogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.105

The Isolation of a New Hypotensive Peptide, Neurotensin, from Bovine Hypothalami

31 March 2020

1 reference

12 December 2020

Neurotensin. Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone

1 reference

12 December 2020

Neurotensin stimulates [3H]oleic acid translocation across rat small intestine

1 reference

12 December 2020

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

1 reference

12 December 2020

Females secrete growth hormone with more process irregularity than males in both humans and rats.

1 reference

12 December 2020

10.1038/NRCARDIO.2015.105

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

26149486